Feb 08, 2016 12:39 pm UTC| Business
UPPSALA, Sweden, Feb. 8, 2016 -- Apealea is a novel formulation of paclitaxel based on the patented excipient platform XR-17, which forms Cremophor(r)-free micellar nanoparticles with paclitaxel. The indication sought for...
Supernus Prevails in Oxtellar XR® ANDA Litigation
Feb 08, 2016 12:30 pm UTC| Business
ROCKVILLE, Md., Feb. 08, 2016 -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases,...
Feb 08, 2016 12:30 pm UTC| Business
COLORADO SPRINGS, Colo., Feb. 08, 2016 -- The Spectranetics Corporation (NASDAQ:SPNC) today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) clearance of the Bridge Occlusion Balloon for...
Raptor Pharmaceutical to Participate in the Leerink Partners 5th Global Healthcare Conference
Feb 08, 2016 12:30 pm UTC| Business
NOVATO, Calif., Feb. 08, 2016 -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will participate in the following investor conference: Julie Anne Smith, President and Chief Executive Officer, will...
Global Blood Therapeutics Announces Changes to Board of Directors
Feb 08, 2016 12:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2016 -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment of grievous blood-based disorders with...
Feb 08, 2016 12:30 pm UTC| Business
MENLO PARK, Calif., Feb. 08, 2016 -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) a pioneer and leader in long-read sequencing using its Single Molecule, Real-Time (SMRT®) technology, today announced more than...
Agios Appoints Steve Hoerter as Chief Commercial Officer
Feb 08, 2016 12:30 pm UTC| Business
CAMBRIDGE, Mass., Feb. 08, 2016 -- Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the appointment of Steve Hoerter to the...